ABSTRACT
In recent years drug prices have increasingly become a topic of debate for patients, providers, payers and policy makers.
To place the current drug price debate into historical context, we searched the New York Times and Wall Street Journal from 1985 – 2015 and found that concerns about drug prices have commonly featured in the press over the study period with recently stronger calls for change.
Price levels, types of innovations, stakeholder responses, and strategies to address high prices discussed in the media suggest that concerted efforts are required to enable affordable and high-value innovations.